Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,837 | -10,444 | -7,845 | N/A | N/A |
| Depreciation Amortization | 755 | 615 | 521 | N/A | N/A |
| Accounts payable and accrued liabilities | 504 | 75 | 146 | N/A | N/A |
| Other Working Capital | -1,209 | 212 | -102 | N/A | N/A |
| Other Operating Activity | 5,653 | -58 | -126 | 0 | 0 |
| Operating Cash Flow | $-12,134 | $-9,600 | $-7,406 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -586 | -233 | -228 | N/A | N/A |
| Investing Cash Flow | $-586 | $-233 | $-228 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 6,800 | N/A | N/A | N/A |
| Debt Repayment | -451 | -612 | -551 | N/A | N/A |
| Common Stock Issued | 44,870 | 5 | N/A | N/A | N/A |
| Other Financing Activity | 5,024 | 4,581 | 0 | 0 | 0 |
| Financing Cash Flow | $49,943 | $10,774 | $-551 | $N/A | $N/A |
| Beginning Cash Position | 2,643 | 1,702 | 9,887 | N/A | N/A |
| End Cash Position | 39,866 | 2,643 | 1,702 | N/A | N/A |
| Net Cash Flow | $37,223 | $941 | $-8,185 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,134 | -9,600 | -7,406 | N/A | N/A |
| Capital Expenditure | -586 | -233 | -228 | N/A | N/A |
| Free Cash Flow | -12,720 | -9,833 | -7,634 | 0 | 0 |